|
|
H2021/CTD8692/20203EUA
|
COVID-19 VACCINE JANSSEN (AD26.COV2-S [RECOMBINANT])
|
COVID-19 VACCINE (AD26.COV2-S [RECOMBINANT])
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Revoked
|
Details →
|
|
|
H2026/CTD13197/26053
|
STELARA 130MG CONCENTRATE FOR SOLUTION FOR INFUSION
|
USTEKINUMAB
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2026/CTD13196/26051
|
STELARA 45MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
|
USTEKINUMAB
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2026/CTD13195/26052
|
STELARA 90MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
|
USTEKINUMAB
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2026/CTD11742/24074
|
ERLEADA TABLET
|
APALUTAMIDE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2011/12885/R1
|
Pariet 20mg Gastro-Resistant Tablet
|
Rabeprazole
|
Janssen Cilag Pharma GmbH
|
Retained
|
Details →
|
|
|
H2015/CTD2304/299/R1
|
EDURANT
|
RILPIVIRINE
|
PHILLIPS THERAPEUTICS LIMITED
|
Registered
|
Details →
|
|
|
H2002/035/R1
|
TOPAMAX 25MG
|
TOPIRAMATE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2000/197/R1
|
TOPAMAX 50MG
|
TOPIRAMATE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|